Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 6OTHER_GOV 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Surgical Wound Infection 1Stomach Neoplasms 1Rectal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

apatinib 25Cisplatin 19Capecitabine 17Irinotecan 16Cyclophosphamide 16fludarabine 14Radiotherapy 12Oxaliplatin 12Drug Therapy 12camrelizumab 11Paclitaxel 11S 1 (combination) 10Docetaxel 10Carboplatin 10Fluorouracil 9Blood Specimen Collection 9Bevacizumab 9Nivolumab 8tislelizumab 7Radiation 7Pemetrexed 7Gemcitabine 7Erlotinib Hydrochloride 7Surgical Procedures, Operative 6Neoadjuvant Therapy 6Albumin-Bound Paclitaxel 6toripalimab 5anlotinib 5XELOX 5Tamoxifen 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER_GOV × Metronidazole × Clear all
NCT06216639 2024-02-09

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

National Institute of Public Health, Slovenia

Unknown
2,000 enrolled
Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03436719 2019-03-05

Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.

State Scientific Centre of Coloproctology, Russian Federation

Phase NA Unknown
280 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡